The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Open accessAbstract
Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in brains of individuals with Alzheimer's disease (AD) and other tauopathies. Tau pathology is critical to pathogenesis and correlates to the severity of dementia. However, the mechanisms leading to abnormal hyperphosphorylation are unknown. Here, we demonstrate that human brain tau was modified by O-GlcNAcylation, a type of protein O-glycosylation by which the monosaccharide β- N -acetylglucosamine (GlcNAc) attaches to serine/threonine residues via an O-linked glycosidic bond. O-GlcNAcylation regulated phosphorylation of tau in a site-specific manner both in vitro and in vivo . At most of the phosphorylation sites, O-GlcNAcylation negatively regulated tau phosphorylation. In an animal model of starved mice, low glucose uptake/metabolism that mimicked those observed in AD brain produced a decrease in O-GlcNAcylation and consequent hyperphosphorylation of tau at the majority of the phosphorylation sites. The O-GlcNAcylation level in AD brain extracts was decreased as compared to that in controls. These results reveal a mechanism of regulation of tau phosphorylation and suggest that abnormal hyperphosphorylation of tau could result from decreased tau O-GlcNAcylation, which probably is induced by deficient brain glucose uptake/metabolism in AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a reduction of glucose consumption induces an increase in phospho-Tau and A β accumulation (Fu et al., 2015; Liu et al., 2004).”
From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Liu et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“For example, reduced tau O-glycosylation could lead to increased phosphorylation, while the enhancement of O-glycosylation reduces the extent of tau phosphorylation [43–45].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
In the citing paper
“As discussed above, a reciprocal relationship has been found between O-GlcNAcylation and phosphorylation on tau [43].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Self-citationA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citation
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Roos, M. D., Xie, W., Su, K., Clark, J. A., Yang, X., Chin, E., Paterson, A. J. & Kudlow, J. E. (1998) Proc. Assoc. Am. Physicians 110, 422-432.9756093
- Iqbal, K. & Grundke-Iqbal, I. (2000) Neurosci. News 3, 14-20.
- Xavier-Blaizot, A., Meguro, K., Millien, I., Baron, J.-C. & Chavoix, C. (2002) J. Neurosci. 21, 9166-9170.
Cited by
Sorted by citations
Items 101–200 of 781
The role of tau phosphorylation and cleavage in neuronal cell death
Chun, W. (2006) · Frontiers in bioscience · doi:10.2741/2097 · Cited by 144
Buchholz, S., & Zempel, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13784 · Cited by 154
Label-Free Detection of Post-translational Modifications with a Nanopore
Restrepo-Pérez, L., Wong, C. H., Maglia, G., Dekker, C., & Joo, C. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03134 · Cited by 143
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
Stamelou, M., Respondek, G., Giagkou, N., Whitwell, J. L., Kovács, G. G., & Höglinger, G. U. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00541-5 · Cited by 149
Strategies for the Inhibition of Protein Aggregation in Human Diseases
Bartolini, M., & Andrisano, V. (2010) · ChemBioChem · doi:10.1002/cbic.200900666 · Cited by 140
O-GlcNAcylation and neurodegeneration
Wani, W. Y., Chatham, J. C., Darley-Usmar, V. M., McMahon, L. L., & Zhang, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.002 · Cited by 134
Wang, S., Yang, F., Petyuk, V., Shukla, A. K., Monroe, M. E., Gritsenko, M. A., Rodland, K., Smith, R. D., Qian, W., Gong, C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4929 · Cited by 134
Self-citationNew Insights Into Drug Discovery Targeting Tau Protein
Soeda, Y., & Takashima, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.590896 · Cited by 136
Smet‐Nocca, C., Broncel, M., Wieruszeski, J., Tokarski, C., Hanoulle, X., Leroy, A., Landrieu, I., Rolando, C. H., Lippens, G. M., & Hackenberger, C. P. R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00337a · Cited by 141
Therapeutic strategies for tau mediated neurodegeneration
Yoshiyama, Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303144 · Cited by 137
Chemical approaches to understanding O-GlcNAc glycosylation in the brain
Rexach, J. E., Clark, P. M., & Hsieh‐Wilson, L. C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.68 · Cited by 129
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody
Yuzwa, S. A., Yadav, A. K., Skorobogatko, Y., Clark, T., Vosseller, K., & Vocadlo, D. J. (2011) · Amino Acids · doi:10.1007/s00726-010-0705-1 · Cited by 130
Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase
Macauley, M. S., & Vocadlo, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.028 · Cited by 131
Tallent, M. K., Varghis, N., Skorobogatko, Y. V., Hernandez‐Cuebas, L., Whelan, K. A., Vocadlo, D. J., & Vosseller, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807431200 · Cited by 128
Patil, S. P., Melrose, J., & Chan, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05797.x · Cited by 129
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
Correia, S. C., & Moreira, P. I. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06443.x · Cited by 125
Thomas, S. N., Funk, K. E., Wan, Y., Liao, Z., Davies, P., Kuret, J., & Yang, A. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0893-0 · Cited by 123
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
Zhou, Y., Shi, J., Chu, D., Hu, W. H., Guan, Z., Gong, C., Iqbal, K., & Liu, F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00027 · Cited by 130
Self-citationAlfaro, F. J., Gavrieli, A., Saade-Lemus, P., Lioutas, V., Upadhyay, J., & Novak, V. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.009 · Cited by 125
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 123
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114
Saha, A., Bello, D., & Fernández‐Tejada, A. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01275k · Cited by 126
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116
Šalković‐Petrišić, M., Barilar, J. O., Grünblatt, E., Riederer, P. F., & Hoyer, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1184 · Cited by 122
GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis
Zibrova, D., Vandermoere, F., Göransson, O., Peggie, M. W., Mariño, K. V., Knierim, A., Spengler, K., Weigert, C., Viollet, B., Morrice, N. A., et al. (2016) · Biochemical Journal · doi:10.1042/bcj20160980 · Cited by 123
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
Yang, Y. S., Tapias, V., Acosta, D. M., Xu, H., Chen, H., Bhawal, R. P., Anderson, E. T., Ivanova, E., Lin, H., Sagdullaev, B. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27572-2 · Cited by 135
Glycosylation and behavioral symptoms in neurological disorders
Pradeep, P., Kang, H., & Lee, B. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02446-x · Cited by 118
Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting
Li, X., Fen, L., Wang, J., & Gong, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04735.x · Cited by 116
Self-citationInterplay between protein glycosylation pathways in Alzheimer’s disease
Frenkel‐Pinter, M., Shmueli, M. D., Raz, C., Yanku, M., Zilberzwige‐Tal, S., Gazit, E., & Segal, D. (2017) · Science Advances · doi:10.1126/sciadv.1601576 · Cited by 115
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113
Lefebvre, T., Dehennaut, V., Guinez, C., Stichelen, S. O.-V., Drougat, L., Mir, A., Mortuaire, M., Vercoutter‐Edouart, A., & Michalski, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.008 · Cited by 119
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yu, Y., Zhang, L., Li, X., Run, X., Liang, Z., Li, Y., Liu, Y., Lee, M. H., Grundke, I., Iqbal, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035277 · Cited by 113
Self-citationO-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
Jacobsen, K. T., & Iverfeldt, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.080 · Cited by 113
O‐GlcNAcylation: A regulator of tau pathology and neurodegeneration
Gong, C., Liu, F., & Iqbal, K. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.011 · Cited by 117
Self-citationTherapeutic strategies for the treatment of tauopathies: Hopes and challenges
Khanna, M. R., Kovalevich, J., Lee, V. M. ‐., Trojanowski, J. Q., & Brunden, K. R. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.006 · Cited by 116
Hyperphosphorylation-Induced Tau Oligomers
Iqbal, K., Gong, C., & Liu, F. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00112 · Cited by 120
Self-citationMulti-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
Gong, C., Dai, C., Liu, F., & Iqbal, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.837649 · Cited by 109
Self-citationAlzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Iqbal, K., Liu, F., & Gong, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.002 · Cited by 114
Self-citationRole of phosphatidylcholine‐DHA in preventing APOE4‐associated Alzheimer's disease
Patrick, R. P. (2018) · The FASEB Journal · doi:10.1096/fj.201801412r · Cited by 118
Pharmacogenomics in Alzheimer's Disease
Cacabelos, R. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-205-2_10 · Cited by 109
O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding
Lewis, Y. E., Galesic, A., Levine, P. M., Leon, C. A. D., Lamiri, N., Brennan, C. K., & Pratt, M. R. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00113 · Cited by 108
Glucose metabolism and AD: evidence for a potential diabetes type 3
González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112
Zhou, J., Liang, Y., He, X., Chen, L., & Zhang, Y. (2017) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.7b02521 · Cited by 107
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
Panza, F., Solfrizzi, V., Seripa, D., Imbimbo, B. P., Lozupone, M., Santamato, A., Tortelli, R., Galizia, I., Prete, C., Daniele, A., et al. (2016) · Immunotherapy · doi:10.2217/imt-2016-0019 · Cited by 113
Liu, Y., Li, X., Yu, Y., Shi, J., Liang, Z., Run, X., Li, Y., Dai, C., Grundke, I., Iqbal, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043724 · Cited by 109
Self-citationAlzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110
Pathological Changes of Tau Related to Alzheimer’s Disease
Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 106
Self-citationO-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
Wani, W. Y., Ouyang, X., Benavides, G. A., Redmann, M., Cofield, S. S., Shacka, J. J., Chatham, J. C., Darley-Usmar, V. M., & Zhang, J. (2017) · Molecular Brain · doi:10.1186/s13041-017-0311-1 · Cited by 105
Yang, Y., Wen, R., Yang, N., Zhang, T., & Liu, C. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00684-9 · Cited by 107
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
Wu, Q., Liang, H., Shi, J., Jin, N., Grundke, I., Iqbal, K., Gong, C., & Liu, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr195 · Cited by 100
Self-citationYang, Z., Gu, J., Dai, C., Liu, Q., Iqbal, K., Liu, F., & Gong, C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00010 · Cited by 100
Self-citationRyan, P., Patel, B., Makwana, V., Jadhav, H. R., Kiefel, M. J., Davey, A. K., Reekie, T. A., Rudrawar, S., & Kassiou, M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00185 · Cited by 101
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 102
Wang, P., Lazarus, B. D., Forsythe, M. E., Love, D. C., Krause, M., & Hanover, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205748109 · Cited by 99
Tau as a Therapeutic Target for Alzheimers Disease
Boutajangout, A., Sigurdsson, E. M., & Krishnamurthy, P. K. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717195 · Cited by 102
Targeting tau: clinical trials and novel therapeutic approaches
VandeVrede, L., Boxer, A. L., & Polydoro, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134919 · Cited by 90
Houck, A. L., Seddighi, S., & Driver, J. A. (2018) · Current Aging Science · doi:10.2174/1874609811666180223154436 · Cited by 96
Targeting O-GlcNAcylation to develop novel therapeutics
Zhu, Y., & Hart, G. W. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100885 · Cited by 92
Self-citationTau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
Rodriguez‐Rodriguez, P., Matton, A., Merino‐Serrais, P., Parrado‐Fernández, C., Rábano, A., Winblad, B. G., Ávila, J., Ferrer, I., & Cedazo-Mínguez, Á. (2017) · Brain · doi:10.1093/brain/awx256 · Cited by 99
Ball, L. E., Berkaw, M. N., & Buse, M. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500314-mcp200 · Cited by 101
Majumdar, G., Harrington, A., Hungerford, J., Martinez-Hernandez, A., Gerling, I., Raghow, R., & Solomon, S. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511223200 · Cited by 94
Metabolic/signal transduction hypothesis of Alzheimer?s disease and other tauopathies
Iqbal, K., & Grundke, I. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0951-y · Cited by 94
Self-citationYin, X., Jin, N., Shi, J., Zhang, Y., Wu, Y., Gong, C.-X., Iqbal, K., & Liu, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-00682-y · Cited by 93
Self-citationPhase separation in viral infections
Li, H., Ernst, C., Kolonko, M., Greb‐Markiewicz, B., Man, J. O. T., Parissi, V., & Ng, W. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.06.005 · Cited by 90
Yang, Y., Zhang, J., Ma, D., Zhang, M., Hu, S., Shao, S., & Gong, C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130491 · Cited by 92
Self-citationWang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92
Domenico, F. D., Rukhsana Sultana, A., Barone, E., Marzia Perluigi, A., Cini, C., Mancuso, C., Cai, J., Pierce, W. M. J., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.03.033 · Cited by 91
O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity
Balana, A. T., Levine, P. M., Craven, T. W., Mukherjee, S., Pedowitz, N. J., Moon, S. P., Takahashi, T. T., Becker, C. F. W., Baker, D. A., & Pratt, M. R. (2021) · Nature Chemistry · doi:10.1038/s41557-021-00648-8 · Cited by 90
Tau at the interface between neurodegeneration and neuroinflammation
Didonna, A. (2020) · Genes & Immunity · doi:10.1038/s41435-020-00113-5 · Cited by 82
Di Domenico, F., Tramutola, A., Foppoli, C., Head, E., Perluigi, M., & Butterfield, D. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.009 · Cited by 89
Targeting Tau Protein in Alzheimerʼs Disease
Gong, C., Grundke, I., & Iqbal, K. (2010) · Drugs & Aging · doi:10.2165/11536110-000000000-00000 · Cited by 90
Self-citationGlycan Antagonists and Inhibitors: A Fount for Drug Discovery
Brown, J. R., Crawford, B. E., & Esko, J. D. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701751611 · Cited by 88
Brister, M., Pandey, A. K., Bielska, A. A., & Zondlo, N. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja407156m · Cited by 89
Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes
Gibson, G. E., Hirsch, J. A., Cirio, R. T., Jordan, B. D., Fonzetti, P., & Elder, J. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.001 · Cited by 90
Tau-induced neurodegeneration: mechanisms and targets
Beharry, C., Cohen, L. S., Di, J., Ibrahim, K., Briffa-Mirabella, S., & Alonso, A. D. C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1414-z · Cited by 92
Therapeutic applications of iminosugars: Current perspectives and future opportunities
Horne, G., & Wilson, F. X. (2011) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-381290-2.00004-5 · Cited by 87
Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10
Shi, J., Qian, W., Yin, X., Iqbal, K., Grundke, I., Gu, X., Ding, F., Gong, C., & Liu, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204453 · Cited by 87
Self-citationThe O-GlcNAc ModificationPreprint
Hart, G. W., & Akimoto, Y. (2009) · Europe PMC (PubMed Central) · doi:10.1101/glycobiology.3e.019 · Cited by 87
Self-citationO-GlcNAc transferase inhibitors: current tools and future challenges
Trapannone, R., Rafie, K., & van Aalten, D. M. F. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150189 · Cited by 86
Ryan, P., Xu, M., Davey, A. K., Danon, J. J., Mellick, G. D., Kassiou, M., & Rudrawar, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00143 · Cited by 84
Chen, S., Li, B., Grundke, I., & Iqbal, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709852200 · Cited by 84
Self-citationDeregulation of brain insulin signaling in Alzheimer’s disease
Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 82
Self-citationEngineering Biological Nanopore Approaches toward Protein Sequencing
Wei, X., Penkauskas, T., Reiner, J. E., Kennard, C., Uline, M. J., Wang, Q., Li, S., Aksimentiev, A., Robertson, J. W. F., & Liu, C. (2023) · ACS Nano · doi:10.1021/acsnano.3c05628 · Cited by 81
Is Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?
Frisardi, V., Solfrizzi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Seripa, D., Pilotto, A., & Panza, F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100015 · Cited by 85
Nutrient‐driven O‐Glc NA c in proteostasis and neurodegeneration
Akan, I., Stichelen, S. O.-V., Bond, M. R., & Hanover, J. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14242 · Cited by 84
Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 84
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
Abreha, M. H., Dammer, E. B., Ping, L., Zhang, T., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · PROTEOMICS · doi:10.1002/pmic.201800108 · Cited by 82
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80
Chen, Z., Yu, Q., Yu, Q., Johnson, J., Shipman, R. D., Zhong, X., Huang, J., Asthana, S., Carlsson, C. M., Okonkwo, O. C., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100081 · Cited by 84
Budnar, S., Vaidya, M. M., & Kalraiya, R. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098996 · Cited by 83
Šalković‐Petrišić, M., Barilar, J. O., Knezović, A., Hoyer, S., Mosetter, K., & Reutter, W. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.002 · Cited by 83
Leon, C. A. D., Levine, P. M., Craven, T. W., & Pratt, M. R. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00268 · Cited by 81
Wang, X., Li, W., Marcus, J., Pearson, M. S., Song, L., Smith, K. D. B., Terracina, G., Lee, J. A., Hong, K.-L. K., Lu, S. X., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266122 · Cited by 85
Deng, Y., Li, B., Liu, F., Iqbal, K., Grundke, I., Brandt, R., & Gong, C. (2007) · The FASEB Journal · doi:10.1096/fj.07-8309com · Cited by 80
Self-citationCan Alzheimer Disease Be a Form of Type 3 Diabetes?
Accardi, G., Caruso, C., Colonna‐Romano, G., Camarda, C., Monastero, R., & Candore, G. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1289 · Cited by 79
Animal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 82
Xie, S.-T., Jin, N., Gu, J., Shi, J., Sun, J., Chu, D., Zhang, L. N., Dai, C., Gu, J., Gong, C., et al. (2016) · Aging Cell · doi:10.1111/acel.12449 · Cited by 85
Self-citation
Metadata
- Authors
- Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X.
- Affiliations
- Johns Hopkins University (US)
- Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314; and Department of Biological Chemistry, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205
- Corresponding author
- Gong, Cheng-Xin
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10804-10809
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490015
- OpenAlex
- W2164029759
- Cited by
- 775
- References
- 42
- Citations by year
- 2026: 29 · 2025: 50 · 2024: 38 · 2023: 36 · 2022: 44 · 2021: 63 · 2020: 57 · 2019: 38 · 2018: 46 · 2017: 45 · 2016: 33 · 2015: 23 · 2014: 36 · 2013: 24 · 2012: 35
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nanjing Medical University
- National Institutes of Health (HD13563)
- National Institute on Aging (AG19158, R01AG019158, AG16760, R01AG016760)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD013563, HD13563)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- O-GlcNAcylation, tau protein, tau hyperphosphorylation, Alzheimer's disease, tauopathy, neurofibrillary tangles, O-glycosylation, glucose metabolism, brain glucose uptake
- MeSH terms
- Acetylglucosamine, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Female, Glycosylation, Humans, Male, Mice, Inbred C57BL, Middle Aged, Phosphorylation, Starvation, PC12 Cells, tau Proteins, Rats, Wistar, Mice, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
